Case Report: Multiple Causes of Cardiac Death After the First Infusion of Atezolizumab: Histopathological and Immunohistochemical Findings

Immune checkpoint inhibitors are promising agents for anticancer therapy. But despite their high efficacy in the treatment of solid tumors, there is still a problem with immune-related adverse events, especially cardiovascular complications with a very high mortality rate. Myocarditis or ischemic he...

Descripción completa

Detalles Bibliográficos
Autores principales: Kushnareva, Ekaterina, Stepanova, Maria, Artemeva, Elizaveta, Shuginova, Tatyana, Kushnarev, Vladimir, Simakova, Maria, Moiseenko, Fedor, Moiseeva, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008445/
https://www.ncbi.nlm.nih.gov/pubmed/35432332
http://dx.doi.org/10.3389/fimmu.2022.871542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008445/
https://www.ncbi.nlm.nih.gov/pubmed/35432332
http://dx.doi.org/10.3389/fimmu.2022.871542

Ejemplares similares